Melanotan 2
Melanotan II (MT-2)
Originally designed for sunless tanning, this peptide also powerfully enhances libido and suppresses appetite through the same brain pathways as PT-141.
Melanotan 2 (MT-2) is a synthetic peptide that mimics alpha-melanocyte stimulating hormone, which is the hormone your body naturally uses to control skin pigmentation. When you inject MT-2, it stimulates your skin's pigment-producing cells to make more melanin, giving you a tan without needing to spend significant time in the sun. It was originally developed at the University of Arizona in the 1990s as a potential sunless tanning agent, but researchers quickly discovered it had some surprising bonus effects on sexual arousal and appetite.
The discovery of MT-2's sexual side effects is one of those great stories in science. During early testing, one researcher famously experienced an eight-hour erection after accidentally injecting twice his intended dose. That unexpected finding eventually led to the development of PT-141 (bremelanotide), a related peptide that was refined specifically for sexual dysfunction and went on to earn FDA approval. MT-2 is essentially the parent compound, offering tanning, libido enhancement, and appetite suppression all in one package.
MT-2 is not FDA approved for any use and is sold as a research compound. It gained significant popularity in fitness, bodybuilding, and aesthetic communities as a way to achieve a deep, natural-looking tan without extensive sun exposure. It also developed a following among people seeking enhanced libido. The compound is administered via injection, typically in a loading phase where you build up pigmentation over several weeks, followed by maintenance doses to keep the color.
How It Works
MT-2 works by activating a family of receptors called melanocortin receptors, and it is not picky about which ones it activates. This non-selectivity is what gives it such a wide range of effects. The MC1R receptor, found on the pigment-producing cells in your skin called melanocytes, is responsible for the tanning effect. When MT-2 binds to these receptors, your melanocytes ramp up melanin production and transfer that pigment to surrounding skin cells. Think of it like turning up the volume on your skin's natural tanning machinery, even without much sun exposure.
The MC3R and MC4R receptors, found in the brain, explain the sexual and appetite effects. These are the same receptors that PT-141 targets. When MT-2 activates MC4R, it increases sexual arousal and erectile response. Both MC3R and MC4R also influence hunger signals, which is why many users experience noticeably decreased appetite and find it easier to stick to a diet. Essentially, one peptide is flipping multiple switches across your body: tanning in the skin, desire in the brain, and appetite suppression in the hypothalamus.
The tanning effect from MT-2 is gradual and cumulative. Unlike a natural tan that requires UV radiation to trigger melanin production, MT-2 directly tells your melanocytes to produce pigment. Some UV exposure accelerates and deepens the results, but it is not strictly required. Initial darkening is usually visible within 7 to 10 days, with full effects developing over 4 to 8 weeks. The sexual effects are more immediate, typically kicking in within 2 to 6 hours of injection and lasting 6 to 24 or more hours. After you stop using MT-2, the pigmentation slowly fades over weeks to months.
Potential Benefits
Deep Tan With Minimal Sun Exposure
MT-2 produces natural-looking skin pigmentation by directly stimulating your melanocytes, dramatically reducing the amount of UV exposure needed to achieve and maintain a tan. You can maintain a year-round tan regardless of climate or season, with significantly less time in the sun than traditional tanning requires.
Reduced UV Damage Risk
Because you need far less sun exposure to achieve pigmentation with MT-2, you accumulate less cumulative UV damage to your skin. The melanin that MT-2 helps produce also provides a degree of natural sun protection, reducing your risk of sunburn and potentially slowing the photoaging process.
Enhanced Libido and Sexual Function
Through activation of MC3R and MC4R receptors in the brain, MT-2 increases sexual desire in both men and women, improves erectile function in men, and enhances overall arousal and response. These effects typically begin 2 to 6 hours after injection and can last a full day or longer.
Appetite Suppression
Many users report a noticeable decrease in hunger and food cravings while using MT-2, making it easier to stick to calorie-restricted diets. This effect comes from the same melanocortin receptor activation in the brain that controls energy balance and appetite signaling.
Enhanced Muscle Definition and Aesthetics
A darker skin tone naturally enhances the visibility of muscle definition, which is why MT-2 is popular in fitness and bodybuilding communities. It provides a consistent, even tan without tan lines, which is valued for competitions, photoshoots, and general appearance.
What the Research Shows
MT-2 was studied in early clinical trials but was never brought through the full regulatory process for cosmetic tanning use. The foundational Phase 1 study by Dorr and colleagues in 1996 at the University of Arizona tested daily subcutaneous MT-2 at doses ranging from 0.01 to 0.03 mg per kilogram of body weight over two weeks. The results showed that MT-2 clearly produced skin darkening, with two subjects showing increased pigmentation on the face, upper body, and buttocks that persisted even a week after dosing ended. Importantly, they demonstrated that as few as 5 low doses given every other day could produce visible tanning. Side effects included nausea, facial flushing, and spontaneous erections lasting 1 to 5 hours.
One of the biggest questions about MT-2 is whether it increases the risk of melanoma, the most serious form of skin cancer. The current evidence is reassuring but not definitive. Case reports of melanoma in MT-2 users exist, but these cases consistently coincide with heavy UV exposure, which is itself a major melanoma risk factor. A 2013 review found no conclusive evidence that MT-2 causes melanoma, and a 2021 review concluded that increased melanoma in users was likely explained by greater UV exposure rather than the peptide itself. Interestingly, a 2020 study actually found that MT-2 suppressed melanoma progression in mice. MT-2 does cause reversible darkening of existing moles and freckles, which is well documented and expected, with color returning to baseline after discontinuation.
MT-2's effects on sexual function are well established mechanistically, as these same melanocortin pathways led to the development of PT-141, which earned FDA approval for sexual dysfunction. The libido enhancement works through the same central brain pathways, affecting both desire and physical response. The appetite suppression effects are also consistently reported, though large controlled studies specifically on this aspect are limited.
What to Know
Nausea is the most frequent side effect, especially early in use and at higher doses. It typically improves after the first 1 to 2 weeks. Facial flushing, fatigue, and headache are also common initial reactions.
Darkening of existing moles, freckles, lips, and gums is expected and well documented. New freckles may also appear. These changes are generally reversible after discontinuing MT-2.
Spontaneous erections can occur in men and may be pronounced, especially at higher doses. Decreased appetite, while often desired, can be significant. Mood changes have been reported by some users.
The long-term effects on melanoma risk remain unresolved. While current evidence does not conclusively link MT-2 to melanoma, anyone with a personal or family history of melanoma or atypical moles should avoid MT-2. Professional skin screening is recommended before and during use.
MT-2 is not approved by the FDA or most regulatory agencies for any indication. People with significant cardiovascular disease, uncontrolled hypertension, or who are pregnant or breastfeeding should not use it.
Users should carefully monitor all moles for changes in asymmetry, border regularity, color, and diameter while using MT-2. Fair-skinned individuals should start at very low doses to avoid excessive or uneven pigmentation.
Research References
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
Dorr RT, Lines R, Levine N, et al. · Life Sciences · 1996
Phase 1 human trial demonstrating that subcutaneous MT-2 produced visible skin tanning with as few as 5 doses. Side effects included nausea, flushing, and spontaneous erections lasting 1 to 5 hours.
View StudyInduction of skin tanning by subcutaneous administration of a potent synthetic melanotropin
Levine N, Sheftel SN, Eytan T, et al. · JAMA · 1991
Early study establishing that synthetic melanotropins like MT-2 could induce skin pigmentation through subcutaneous administration, laying the groundwork for further clinical development.
View StudyAlpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects
Brzoska T, Luger TA, Maaser C, et al. · Endocrine Reviews · 2008
Comprehensive review of melanocortin peptides including MT-2, covering their biochemistry, anti-inflammatory properties, and protective effects, as well as future therapeutic perspectives.
View StudyMelanotan II injection resulting in systemic toxicity and rhabdomyolysis
Nelson ME, Bryant SM, Aks SE · Clinical Toxicology · 2012
Case report documenting serious adverse effects from MT-2 misuse, highlighting the importance of proper dosing and the risks of using unregulated compounds without medical supervision.
View Study